Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Why Psyence Biomedical (PBM) Stock Is Skyrocketing
Nasdaq Gains 1%; American Airlines Cuts Earnings Forecast
Dow Jumps 200 Points; Honeywell Trims Profit Outlook
Why Indivior Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
AT&T, Group 1 Automotive, Mattel, Seagate And Other Big Stocks Moving Higher On Wednesday
Compass a New Outperform at RBC on Optimism for Psychedelic-based Therapies
Alkermes Q2 2024 Earnings Preview
Notable Earnings Before Wednesday's Open
RBC Capital Initiates Coverage On Compass Pathways With Outperform Rating, Announces Price Target of $23
NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday
Needham Maintains Buy on Intra-Cellular Therapies, Raises Price Target to $100
6 Analysts Assess Alkermes: What You Need To Know
Earlier, Relmada Therapeutics Announced Publication Of Results From The Phase 3 Reliance I Study of REL-1017 In The Journal Of Clinical Psychiatry
Psyence Biomedical Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
China's Bilibili And Ollie's Bargain Outlet Were Among 10 Mid Cap Stocks With Biggest Gains In The Last Week (June 16-June 22, 2024): Are They In Your Portfolio?
Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Mind Medicine Analyst Ratings
Compass Pathways Analyst Ratings